AR105556A1 - Derivados de etinilo - Google Patents
Derivados de etiniloInfo
- Publication number
- AR105556A1 AR105556A1 ARP160102335A ARP160102335A AR105556A1 AR 105556 A1 AR105556 A1 AR 105556A1 AR P160102335 A ARP160102335 A AR P160102335A AR P160102335 A ARP160102335 A AR P160102335A AR 105556 A1 AR105556 A1 AR 105556A1
- Authority
- AR
- Argentina
- Prior art keywords
- lower alkyl
- halogen
- substituted
- pyridinyl
- pyrimidinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Reivindicación1: Un compuesto de fórmula (1), donde R¹ es hidrógeno, F o Cl; L es un enlace o alquileno inferior; R² es -(CH₂)ₙ-alquilo inferior, alquilo inferior sustituido por halógeno, -(CH₂)ₙC(O)O-alquilo inferior, fenilo sustituido por alquilo inferior o halógeno, o es un grupo heteroarilo de 5 ó 6 miembros, seleccionado entre piridinilo, pirimidinilo, piridazinilo, tiazolilo, imidazolilo, pirazolilo o triazolilo, que están opcionalmente sustituidos por alquilo inferior, halógeno, alcoxi inferior, =O, benciloxi, cicloalcoxi, hidroxi, ciano, alquilo inferior sustituido por halógeno, o por -(CH₂)ₙ-alquilo inferior; n es 1, 2 ó 3; R³ es hidrógeno, alquilo inferior o -(CH₂)ₙ-alquilo inferior; R⁴ es fenilo, piridinilo o pirimidinilo, opcionalmente sustituido por F; Y es CF o CCl; o a una sal farmacéuticamente aceptable o sal de adición ácida, a una mezcla racémica, o a su correspondiente enantiómero y/o isómero óptico y/o estereoisómeros de los mismos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15179550 | 2015-08-03 | ||
| PCT/EP2016/068359 WO2017021384A1 (en) | 2015-08-03 | 2016-08-02 | Ethynyl derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR105556A1 true AR105556A1 (es) | 2017-10-18 |
Family
ID=53776452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102335A AR105556A1 (es) | 2015-08-03 | 2016-08-01 | Derivados de etinilo |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10011607B2 (es) |
| EP (1) | EP3331882B1 (es) |
| JP (1) | JP6975511B2 (es) |
| KR (1) | KR20180030857A (es) |
| CN (1) | CN107667107B (es) |
| AR (1) | AR105556A1 (es) |
| AU (1) | AU2016302696B2 (es) |
| BR (1) | BR112017023951A2 (es) |
| CA (1) | CA2983908A1 (es) |
| CL (1) | CL2018000278A1 (es) |
| CO (1) | CO2017011010A2 (es) |
| HK (1) | HK1246790A1 (es) |
| IL (1) | IL255103B (es) |
| MX (1) | MX2018001486A (es) |
| PE (1) | PE20180357A1 (es) |
| PH (1) | PH12018500247A1 (es) |
| RU (1) | RU2722014C9 (es) |
| TW (1) | TWI621619B (es) |
| UA (1) | UA120888C2 (es) |
| WO (1) | WO2017021384A1 (es) |
| ZA (1) | ZA201707015B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017023905A1 (en) | 2015-08-03 | 2017-02-09 | Bristol-Myers Squibb Company | Heterocyclic compounds useful as modulators of tnf alpha |
| GB201513742D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| US9975887B2 (en) | 2015-08-03 | 2018-05-22 | Glenmark Pharmaceuticals S.A. | Compounds as ROR gamma modulators |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2012121631A (ru) * | 2009-11-06 | 2013-12-20 | Вандербилт Юниверсити | АРИЛ- И ГЕТЕРОАРИЛСУЛЬФОНЫ КАК АЛЛОСТЕРИЧЕСКИЕ СРЕДСТВА ПОТЕНЦИРОВАНИЯ mGluR4, КОМПОЗИЦИИ И СПОСОБЫ ЛЕЧЕНИЯ НЕВРОЛОГИЧЕСКИХ ДИСФУНКЦИЙ |
| US8420661B2 (en) * | 2010-04-13 | 2013-04-16 | Hoffmann-La Roche Inc. | Arylethynyl derivatives |
| EP2702050B1 (en) * | 2011-04-26 | 2016-05-18 | F.Hoffmann-La Roche Ag | Pyrazolidin-3-one derivatives |
| BR112016005994A2 (pt) * | 2013-09-25 | 2017-08-01 | Hoffmann La Roche | derivados de etinila |
| TWI649310B (zh) * | 2014-01-10 | 2019-02-01 | 赫孚孟拉羅股份公司 | 乙炔基衍生物 |
| CA2938009A1 (en) * | 2014-02-25 | 2015-09-03 | F. Hoffmann-La Roche Ag | Ethynyl derivatives |
-
2016
- 2016-08-01 AR ARP160102335A patent/AR105556A1/es unknown
- 2016-08-02 RU RU2018105872A patent/RU2722014C9/ru active
- 2016-08-02 MX MX2018001486A patent/MX2018001486A/es active IP Right Grant
- 2016-08-02 UA UAA201801410A patent/UA120888C2/uk unknown
- 2016-08-02 JP JP2018505431A patent/JP6975511B2/ja active Active
- 2016-08-02 CA CA2983908A patent/CA2983908A1/en not_active Abandoned
- 2016-08-02 TW TW105124484A patent/TWI621619B/zh not_active IP Right Cessation
- 2016-08-02 AU AU2016302696A patent/AU2016302696B2/en not_active Ceased
- 2016-08-02 EP EP16745473.5A patent/EP3331882B1/en active Active
- 2016-08-02 KR KR1020187003005A patent/KR20180030857A/ko not_active Application Discontinuation
- 2016-08-02 CN CN201680029481.6A patent/CN107667107B/zh active Active
- 2016-08-02 WO PCT/EP2016/068359 patent/WO2017021384A1/en active Application Filing
- 2016-08-02 PE PE2017002405A patent/PE20180357A1/es unknown
- 2016-08-02 BR BR112017023951-5A patent/BR112017023951A2/pt not_active Application Discontinuation
-
2017
- 2017-10-17 ZA ZA2017/07015A patent/ZA201707015B/en unknown
- 2017-10-18 IL IL255103A patent/IL255103B/en active IP Right Grant
- 2017-10-27 CO CONC2017/0011010A patent/CO2017011010A2/es unknown
-
2018
- 2018-01-10 US US15/867,097 patent/US10011607B2/en active Active
- 2018-01-31 CL CL2018000278A patent/CL2018000278A1/es unknown
- 2018-02-01 PH PH12018500247A patent/PH12018500247A1/en unknown
- 2018-05-16 HK HK18106336.0A patent/HK1246790A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018522037A (ja) | 2018-08-09 |
| PE20180357A1 (es) | 2018-02-21 |
| IL255103B (en) | 2020-01-30 |
| MX2018001486A (es) | 2018-03-15 |
| ZA201707015B (en) | 2018-11-28 |
| US20180127429A1 (en) | 2018-05-10 |
| RU2722014C9 (ru) | 2020-10-22 |
| EP3331882B1 (en) | 2020-04-29 |
| CA2983908A1 (en) | 2017-02-09 |
| WO2017021384A1 (en) | 2017-02-09 |
| JP6975511B2 (ja) | 2021-12-01 |
| AU2016302696B2 (en) | 2020-05-07 |
| RU2018105872A3 (es) | 2019-12-26 |
| IL255103A0 (en) | 2017-12-31 |
| HK1246790A1 (zh) | 2018-09-14 |
| UA120888C2 (uk) | 2020-02-25 |
| KR20180030857A (ko) | 2018-03-26 |
| US10011607B2 (en) | 2018-07-03 |
| CL2018000278A1 (es) | 2018-07-06 |
| CN107667107A (zh) | 2018-02-06 |
| RU2722014C2 (ru) | 2020-05-26 |
| PH12018500247A1 (en) | 2018-08-13 |
| TW201718589A (zh) | 2017-06-01 |
| TWI621619B (zh) | 2018-04-21 |
| CO2017011010A2 (es) | 2018-02-09 |
| RU2018105872A (ru) | 2019-09-05 |
| AU2016302696A1 (en) | 2017-11-02 |
| CN107667107B (zh) | 2021-05-18 |
| EP3331882A1 (en) | 2018-06-13 |
| BR112017023951A2 (pt) | 2018-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
| AR108710A1 (es) | Compuestos modulares de fxr (nr1h4) | |
| AR095421A1 (es) | Moduladores de p2x7 | |
| AR094346A1 (es) | Derivados de azaindol como inhibidores de las proteína quinasas | |
| RS54183B1 (en) | PIRAZOLE DERIVATIVES | |
| AR095011A1 (es) | Compuestos de antranilamida, sus mezclas y usos como plaguicidas | |
| AR105341A1 (es) | Derivados de etinilo como moduladores metabotrópicos del receptor del glutamato | |
| AR105845A1 (es) | Compuestos de heteroarilo bicíclicos fusionados como moduladores de la función irak4 | |
| AR094887A1 (es) | Derivado de tetrahidroimidazol[1,5-d][1,4]oxazepina | |
| AR085615A1 (es) | Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen | |
| AR094314A1 (es) | Inhibidores de fosfatidilinositol 3-cinasa | |
| AR089671A1 (es) | 1,4-dihidropirimidinas 4,4-disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
| AR095423A1 (es) | 2-azabiciclos sustituidos y su uso como moduladores del receptor de orexina | |
| AR099177A1 (es) | Determinadas (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1 | |
| WO2015004566A3 (en) | Liquid bisacylphosphine oxide photoinitiator | |
| AR091519A1 (es) | Inhibidores pirrolopirazona de tanquirasa | |
| AR090328A1 (es) | Pirrolidina-2-carboxamidas sustituidas | |
| RS53843B1 (en) | BIS (FLUOROALKYL) -1,4-BENZODIAZEPINONE COMPOUNDS | |
| AR091271A1 (es) | Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa | |
| AR085088A1 (es) | Inhibidores de histona desacetilasa y composiciones farmaceuticas que los contienen | |
| AR098522A1 (es) | Compuesto de triazolo-piridina | |
| AR093937A1 (es) | Compuestos quimicos | |
| AR104331A1 (es) | Derivados de tetrazol | |
| AR097866A1 (es) | Derivados de 4-azaindol | |
| ES2421896T3 (es) | Compuestos de aril-(imidazol)-metil-fenilo sustituidos como moduladores selectivos de los subtipos de receptores adrenérgicos alfa 2B y/o alfa 2C |